Rheumatoid Arthritis Therapeutics Market 2027 By Product Type, Distribution Channel and Geography | The Insight Partners

Rheumatoid Arthritis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Pharmaceuticals, Biologics and biosimilars); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00017833 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Rheumatoid arthritis (RA) is a chronic inflammatory disease, which generally leads to disability, progressive joint deformity, and occasionally premature death. RA may affect many tissues and organs, but it principally attacks the joints, producing an inflammatory synovitis that often progresses to destruction of the articular cartilage and ankylosis of the joints. The treatment options available for rheumatoid arthritis are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs) and biologic response modifiers (biologics).

MARKET DYNAMICS

The Rheumatoid Arthritis Therapeutics market is driving due to the rise in prevalence of arthritis, increasing acceptance of biopharmaceuticals, and presence of well-defined regulatory guidelines in developed economies. However, the accessibility of the treatment, patent expiration of blockbuster drugs and alternative treatment options for rheumatoid arthritis are projected to hamper the market growth.

MARKET SCOPE

The "Rheumatoid Arthritis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Rheumatoid Arthritis Therapeutics market with detailed market segmentation by product type and distribution channel . The Rheumatoid Arthritis Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Rheumatoid Arthritis Therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Rheumatoid Arthritis Therapeutics market is segmented on the basis of product type and distribution channel. Based on product type, the market is segmented as pharmaceuticals and biologics & biosimilars. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Rheumatoid Arthritis Therapeutics market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Rheumatoid Arthritis Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Rheumatoid Arthritis Therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Rheumatoid Arthritis Therapeutics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Rheumatoid Arthritis Therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rheumatoid Arthritis Therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for Rheumatoid Arthritis Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Rheumatoid Arthritis Therapeutics market.

The report also includes the profiles of key players in Rheumatoid Arthritis Therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AbbVie
  •  Regeneron Pharmaceuticals, Inc.
  •  Novartis International AG
  •  Pfizer Inc.
  •  Bristol-Myers Squibb.
  •  Hoffmann-La Roche AG
  •  Johnson and Johnson
  •  Boehringer Ingelheim GmbH
  •  UCB S.A.
  •  Amgen Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rheumatoid Arthritis Therapeutics Market - By Product Type
1.3.2 Rheumatoid Arthritis Therapeutics Market - By Distribution Channel
1.3.3 Rheumatoid Arthritis Therapeutics Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. RHEUMATOID ARTHRITIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. RHEUMATOID ARTHRITIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHARMACEUTICALS
7.3.1. Overview
7.3.2. Pharmaceuticals Market Forecast and Analysis
7.4. BIOLOGICS AND BIOSIMILARS
7.4.1. Overview
7.4.2. biologics and biosimilars Market Forecast and Analysis
8. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Rheumatoid Arthritis Therapeutics Market Overview
9.1.2 North America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis
9.1.3 North America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Product Type
9.1.4 North America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Rheumatoid Arthritis Therapeutics Market
9.1.5.1.1 United States Rheumatoid Arthritis Therapeutics Market by Product Type
9.1.5.1.2 United States Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.1.5.2 Canada Rheumatoid Arthritis Therapeutics Market
9.1.5.2.1 Canada Rheumatoid Arthritis Therapeutics Market by Product Type
9.1.5.2.2 Canada Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Rheumatoid Arthritis Therapeutics Market
9.1.5.3.1 Mexico Rheumatoid Arthritis Therapeutics Market by Product Type
9.1.5.3.2 Mexico Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Rheumatoid Arthritis Therapeutics Market Overview
9.2.2 Europe Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis
9.2.3 Europe Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Product Type
9.2.4 Europe Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Rheumatoid Arthritis Therapeutics Market
9.2.5.1.1 Germany Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.1.2 Germany Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2.5.2 France Rheumatoid Arthritis Therapeutics Market
9.2.5.2.1 France Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.2.2 France Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2.5.3 Italy Rheumatoid Arthritis Therapeutics Market
9.2.5.3.1 Italy Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.3.2 Italy Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2.5.4 Spain Rheumatoid Arthritis Therapeutics Market
9.2.5.4.1 Spain Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.4.2 Spain Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Rheumatoid Arthritis Therapeutics Market
9.2.5.5.1 United Kingdom Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.5.2 United Kingdom Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.2.5.6 Rest of Europe Rheumatoid Arthritis Therapeutics Market
9.2.5.6.1 Rest of Europe Rheumatoid Arthritis Therapeutics Market by Product Type
9.2.5.6.2 Rest of Europe Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Overview
9.3.2 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Rheumatoid Arthritis Therapeutics Market
9.3.5.1.1 Australia Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.1.2 Australia Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3.5.2 China Rheumatoid Arthritis Therapeutics Market
9.3.5.2.1 China Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.2.2 China Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3.5.3 India Rheumatoid Arthritis Therapeutics Market
9.3.5.3.1 India Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.3.2 India Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3.5.4 Japan Rheumatoid Arthritis Therapeutics Market
9.3.5.4.1 Japan Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.4.2 Japan Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Rheumatoid Arthritis Therapeutics Market
9.3.5.5.1 South Korea Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.5.2 South Korea Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Rheumatoid Arthritis Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Rheumatoid Arthritis Therapeutics Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Overview
9.4.2 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Rheumatoid Arthritis Therapeutics Market
9.4.5.1.1 South Africa Rheumatoid Arthritis Therapeutics Market by Product Type
9.4.5.1.2 South Africa Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Rheumatoid Arthritis Therapeutics Market
9.4.5.2.1 Saudi Arabia Rheumatoid Arthritis Therapeutics Market by Product Type
9.4.5.2.2 Saudi Arabia Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.4.5.3 U.A.E Rheumatoid Arthritis Therapeutics Market
9.4.5.3.1 U.A.E Rheumatoid Arthritis Therapeutics Market by Product Type
9.4.5.3.2 U.A.E Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Rheumatoid Arthritis Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Rheumatoid Arthritis Therapeutics Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Rheumatoid Arthritis Therapeutics Market Overview
9.5.2 South and Central America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Rheumatoid Arthritis Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Rheumatoid Arthritis Therapeutics Market
9.5.5.1.1 Brazil Rheumatoid Arthritis Therapeutics Market by Product Type
9.5.5.1.2 Brazil Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Rheumatoid Arthritis Therapeutics Market
9.5.5.2.1 Argentina Rheumatoid Arthritis Therapeutics Market by Product Type
9.5.5.2.2 Argentina Rheumatoid Arthritis Therapeutics Market by Distribution Channel
9.5.5.3 Rest of South and Central America Rheumatoid Arthritis Therapeutics Market
9.5.5.3.1 Rest of South and Central America Rheumatoid Arthritis Therapeutics Market by Product Type
9.5.5.3.2 Rest of South and Central America Rheumatoid Arthritis Therapeutics Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. RHEUMATOID ARTHRITIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ABBVIE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. REGENERON PHARMACEUTICALS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS INTERNATIONAL AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL-MYERS SQUIBB
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. HOFFMANN-LA ROCHE AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JOHNSON AND JOHNSON
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BOEHRINGER INGELHEIM GMBH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. UCB S.A.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AMGEN INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. AbbVie
2. Regeneron Pharmaceuticals, Inc.
3. Novartis International AG
4. Pfizer Inc.
5. Bristol-Myers Squibb
6. Hoffmann-La Roche AG
7. Johnson and Johnson
8. Boehringer Ingelheim GmbH
9. UCB S.A.
10. Amgen Inc.
TIPRE00017833
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking